tradingkey.logo
tradingkey.logo
Search

Prime Medicine Inc

PRME
Add to Watchlist
2.930USD
-0.200-6.39%
Close 05/15, 16:00ETQuotes delayed by 15 min
529.21MMarket Cap
LossP/E TTM
You can find the annual or quarterly income statement of Prime Medicine Inc here for insights into the performance and operational efficiency of Prime Medicine Inc.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
Total revenue
-41.13%856.00K
-61.61%838.00K
486.12%1.23M
--1.11M
146.02%1.45M
--2.18M
--209.00K
--0.00
--591.00K
----
----
----
----
--0.00
----
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Revenue
-41.13%856.00K
-61.61%838.00K
486.12%1.23M
--1.11M
146.02%1.45M
--2.18M
--209.00K
--0.00
--591.00K
----
----
----
----
--0.00
----
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Operating expenses
-4.34%51.51M
6.55%49.45M
1.39%55.20M
-2.12%54.49M
10.04%53.85M
-31.80%46.41M
5.79%54.44M
23.01%55.67M
22.23%48.93M
75.89%68.04M
62.56%51.46M
72.05%45.26M
101.19%40.03M
-35.60%38.69M
203.59%31.66M
228.16%26.30M
234.14%19.90M
2213.28%60.08M
--10.43M
--8.02M
--5.96M
--2.60M
R&D expenses
-15.92%34.10M
1.77%34.71M
9.05%43.99M
-3.94%41.38M
7.38%40.56M
-17.74%34.10M
-1.53%40.34M
24.49%43.07M
22.33%37.77M
42.66%41.46M
63.56%40.97M
82.68%34.60M
125.78%30.88M
-45.05%29.06M
238.47%25.05M
232.57%18.94M
199.54%13.68M
4100.87%52.89M
--7.40M
--5.70M
--4.57M
--1.26M
Depreciation, depletion, and amortization
9.18%1.86M
9.26%1.88M
20.73%1.88M
21.20%1.86M
29.28%1.70M
37.69%1.72M
26.05%1.56M
37.57%1.54M
25.00%1.31M
43.33%1.25M
95.88%1.24M
160.00%1.12M
259.04%1.05M
190.00%870.00K
277.84%631.00K
252.46%430.00K
193.00%293.00K
1204.35%300.00K
--167.00K
--122.00K
--100.00K
--23.00K
Other operating expenses
----
----
----
----
----
----
----
----
----
--13.50M
----
----
----
----
----
----
----
----
----
----
----
----
Operating profit
3.32%-50.65M
-9.92%-48.61M
0.48%-53.97M
4.12%-53.38M
-8.38%-52.39M
35.01%-44.22M
-5.39%-54.23M
-23.01%-55.67M
-20.75%-48.34M
-75.89%-68.04M
-62.56%-51.46M
-72.05%-45.26M
-101.19%-40.03M
35.60%-38.69M
-203.59%-31.66M
-228.16%-26.30M
-234.14%-19.90M
-2213.28%-60.08M
---10.43M
---8.02M
---5.96M
---2.60M
Net non-operating interest income (expenses)
Non-operating interest income
-13.62%1.02M
-29.58%1.08M
63.70%1.14M
21.60%743.00K
--1.18M
--1.54M
--697.00K
--611.00K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Gains from sale of securities
35.69%460.00K
180.39%858.00K
-15.03%752.00K
-64.33%530.00K
--339.00K
--306.00K
--885.00K
--1.49M
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Special income (expenses)
100.00%0.00
813.56%539.00K
576.28%1.45M
73.77%-505.00K
-190.57%-1.06M
-90.71%59.00K
113.62%215.00K
-831.94%-1.93M
168.55%1.17M
137.16%635.00K
-188.26%-1.58M
107.06%263.00K
62.07%-1.70M
-16.58%-1.71M
121.41%1.79M
-138.19%-3.72M
94.48%-4.49M
-209.08%-1.47M
---8.35M
--9.75M
---81.32M
--1.34M
Other non-operating income (expenses)
37.84%51.00K
13.95%49.00K
153.01%44.00K
-53.85%18.00K
-97.61%37.00K
-97.56%43.00K
-103.74%-83.00K
-98.52%39.00K
-27.49%1.55M
90.60%1.77M
205.22%2.22M
1009.24%2.64M
19309.09%2.13M
7616.67%926.00K
72900.00%728.00K
23700.00%238.00K
--11.00K
-97.84%12.00K
---1.00K
--1.00K
--0.00
--555.00K
Income before tax
5.33%-49.12M
-9.00%-46.08M
3.69%-50.58M
5.17%-52.59M
-13.73%-51.89M
35.60%-42.28M
-3.35%-52.52M
-30.95%-55.46M
-15.22%-45.63M
-66.32%-65.64M
-74.40%-50.82M
-42.18%-42.35M
-62.48%-39.60M
35.85%-39.47M
-55.14%-29.14M
-1817.99%-29.79M
72.07%-24.37M
-8715.19%-61.53M
---18.78M
--1.73M
---87.28M
---698.00K
Income tax
----
----
----
100.00%0.00
-100.00%0.00
--0.00
100.00%0.00
-532.26%-134.00K
166.34%134.00K
100.00%0.00
-150.94%-108.00K
107.01%31.00K
62.03%-202.00K
-113.47%-186.00K
108.95%212.00K
-139.53%-442.00K
13.50%-532.00K
-26.03%1.38M
---2.37M
--1.12M
---615.00K
--1.87M
Income after tax
5.33%-49.12M
-9.00%-46.08M
3.69%-50.58M
4.95%-52.59M
-13.39%-51.89M
35.60%-42.28M
-3.57%-52.52M
-30.53%-55.33M
-16.15%-45.76M
-67.10%-65.64M
-72.77%-50.71M
-44.42%-42.38M
-65.26%-39.40M
37.56%-39.28M
-78.83%-29.35M
-4864.29%-29.35M
72.49%-23.84M
-2352.67%-62.91M
---16.41M
--616.00K
---86.66M
---2.56M
Net income from continuous operations
5.33%-49.12M
-9.00%-46.08M
3.69%-50.58M
4.95%-52.59M
-13.39%-51.89M
35.60%-42.28M
-3.57%-52.52M
-30.53%-55.33M
-16.15%-45.76M
-67.10%-65.64M
-72.77%-50.71M
-44.42%-42.38M
-65.26%-39.40M
37.56%-39.28M
-78.83%-29.35M
-4864.29%-29.35M
72.49%-23.84M
-2352.67%-62.91M
---16.41M
--616.00K
---86.66M
---2.56M
Net income attributable to controlling interests
5.33%-49.12M
-9.00%-46.08M
3.69%-50.58M
4.95%-52.59M
-13.39%-51.89M
35.60%-42.28M
-3.57%-52.52M
-30.53%-55.33M
-16.15%-45.76M
-61.69%-65.64M
-41.99%-50.71M
-18.92%-42.38M
-31.04%-39.40M
41.40%-40.60M
-56.80%-35.71M
-745.17%-35.64M
65.78%-30.06M
-1970.32%-69.27M
---22.77M
---4.22M
---87.85M
---3.35M
Preferred share dividend
----
----
----
----
----
----
----
----
----
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-79.35%1.31M
-0.02%6.36M
30.21%6.29M
421.27%6.22M
714.60%6.36M
--6.36M
--4.83M
--1.19M
--781.00K
Net income attributable to common shareholders
5.33%-49.12M
-9.00%-46.08M
3.69%-50.58M
4.95%-52.59M
-13.39%-51.89M
35.60%-42.28M
-3.57%-52.52M
-30.53%-55.33M
-16.15%-45.76M
-61.69%-65.64M
-41.99%-50.71M
-18.92%-42.38M
-31.04%-39.40M
41.40%-40.60M
-56.80%-35.71M
-745.17%-35.64M
65.78%-30.06M
-1970.32%-69.27M
---22.77M
---4.22M
---87.85M
---3.35M
Basic earnings per share
30.04%-0.28
19.51%-0.26
28.13%-0.32
12.30%-0.41
9.49%-0.40
54.51%-0.32
20.57%-0.44
0.92%-0.46
0.97%-0.44
-85.06%-0.71
-45.84%-0.55
-24.01%-0.47
-38.80%-0.44
47.76%-0.38
-56.81%-0.38
-745.21%-0.38
65.78%-0.32
-1970.26%-0.73
---0.24
---0.04
---0.93
---0.04
Diluted earnings per share
30.04%-0.28
19.51%-0.26
28.13%-0.32
12.30%-0.41
9.49%-0.40
54.51%-0.32
20.57%-0.44
0.92%-0.46
0.97%-0.44
-85.06%-0.71
-45.84%-0.55
-24.01%-0.47
-38.80%-0.44
47.76%-0.38
-56.81%-0.38
-745.21%-0.38
65.78%-0.32
-1970.26%-0.73
---0.24
---0.04
---0.93
---0.04
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--

FAQs

What is the income statement?

The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.
KeyAI